Shock, Cardiogenic: all 281 studies
Page 3 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.
- Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients HemodynamicCompletedNCT04451798Not applicable
- Percutaneous Mitral Valve Repair in Cardiogenic Shock: Mitra-Shock StudyStatus unknownNCT04399499
- Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic ShockTerminatedNCT04369573Phase 4
- European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMOStatus unknownNCT04366921
- The Safety and Efficacy of Istaroxime for Pre-Cardiogenic ShockCompletedNCT04325035Phase 2
- Levosimendan for Veno-arterial ECMO WeaningCompletedNCT04323709
- PPCM Observational Study (Peripartum Cardiomyopathy)CompletedNCT04234659
- Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO)Status unknownNCT04224103
- Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac OutputWithdrawnNCT04206865Phase 4
- Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac OutputCompletedNCT04202432
- "Treatment Use of ECMO In Pregnancy or Peripartum Patient."CompletedNCT04144660
- The Current Status and Clinical Outcomes of Patients With Cardiogenic Shock IIStatus unknownNCT04143893
- Global Longitudinal Strain Assessment in Cardiogenic Shock During SepsisStatus unknownNCT04141410
- Acute Kidney Injury in Adult Patients Supported by VA-ECMOCompletedNCT04082312
- Postoperative Respiratory AbnormalitiesStatus unknownNCT04079829
- Adrecizumab in Cardiogenic ShockCompletedNCT03989531Phase 2/3
- Analysis of Endotoxin Activity in Patients With ECMOCompletedNCT03978728
- Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic ShockStatus unknownNCT03968926
- Lower Limb Surveillance During VA-ECLSCompletedNCT03910062
- Post-Cardiotomy Extra-Corporeal Life Support StudyStatus unknownNCT03857217
- Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic ShockStatus unknownNCT03813134Not applicable
- Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.CompletedNCT03773822Phase 3
- Central Venous Pressure (CVP) Changes do Not Predict Preload UnresponsivenessStatus unknownNCT03753672
- Early LA Venting During Venoaterial ECMO SupportCompletedNCT03740711Not applicable
- Ultrasound Study of the Diaphragm Evolution Under ECMOCompletedNCT03736239
- Left Ventricular Volume Index in the Adjustment of Initial Dose of Dobutamine in Heart Failure and Cardiogenic ShockStatus unknownNCT03727282Not applicable
- Blood Management During ECMO for Cardiac SupportCompletedNCT03714048
- Extracorporeal Life Support in Cardiogenic ShockCompletedNCT03637205Not applicable
- The Effects of IABP Prior to Revascularization on Mortality of ACS Patients Complicated With Cardiogenic ShockCompletedNCT03635840Not applicable
- Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS PatientsCompletedNCT03596944
- Veno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.Status unknownNCT03583970
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial InfarctionCompletedNCT03551964Phase 4
- Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)CompletedNCT03549923Phase 4
- Evaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMOStatus unknownNCT03532529
- Transient Circulatory Support in Cardiogenic ShockStatus unknownNCT03528291
- Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic ShockStatus unknownNCT03437369Phase 4
- Microcirculation in Cardiogenic ShockCompletedNCT03436641
- Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on DobutamineStatus unknownNCT03387605Phase 4
- Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective StudyStatus unknownNCT03346824
- Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic ShockStatus unknownNCT03340779Phase 3
- Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMOCompletedNCT03327493Not applicable
- Hemodynamic Assessment in Cardiogenic Shock Regarding the EtiologyStatus unknownNCT03283995
- Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)CompletedNCT03262155
- Milrinone Versus Dobutamine in Critically Ill PatientsCompletedNCT03207165Phase 4
- PULsecath mechanicaL Support EvaluationCompletedNCT03200990Not applicable
- Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic ShockStatus unknownNCT02985008
- Validation of Epworth Richmond's Echocardiography Education Focused YearCompletedNCT02961439
- Epidemiology and Prognostic of the Acute Heart FailureStatus unknownNCT02880358
- The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock PatientsStatus unknownNCT02870946Not applicable
- Registry for Cardiogenic Shock: Utility and Efficacy of Device TherapyTerminatedNCT02790242
- Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)CompletedNCT02754193Not applicable
- French Observatory on the Management of Cardiogenic Shock in 2016CompletedNCT02703038
- Circulating microRNAs in Patients With STEMI Complicated With Cardiogenic ShockStatus unknownNCT02691286
- GLP-1 and Hyperoxia for Organ Protection in Heart SurgeryActive, not recruitingNCT02673931Not applicable
- Study of Multistep Pharmacological and Invasive Management for Cardiogenic ShockCompletedNCT02591771Phase 2
- Renal Resistive Index in Patients With ShockCompletedNCT02558166
- Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial InfarctionCompletedNCT02544594Phase 4
- ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic ShockCompletedNCT02301819Not applicable
- Thoratec Corporation HeartMate PHP™ Cardiogenic Shock TrialTerminatedNCT02279979Not applicable
- The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)CompletedNCT01993745
- Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic ShockCompletedNCT01927549Phase 4
- Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic ShockWithdrawnNCT01901471Phase 2
- Mild Hypothermia in Cardiogenic Shock Complicating Myocardial InfarctionCompletedNCT01890317Not applicable
- Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous CatheterStatus unknownNCT01788956
- Danish Cardiogenic Shock TrialCompletedNCT01633502Not applicable
- CardShock Study and RegistryCompletedNCT01374867
- Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic ShockCompletedNCT01367743Phase 4
- Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) PatientsStatus unknownNCT01089036
- Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility StudyStatus unknownNCT00846222Phase 3
- Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon CounterpulsationCompletedNCT00604331Phase 2
- Intraaortic Balloon Pump in Cardiogenic Shock IICompletedNCT00491036Phase 4
- Aortic Balloon Counterpulastion in Myocardial Infarction Related ShockCompletedNCT00469248Not applicable
- Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic ShockCompletedNCT00420030Phase 4
- Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)CompletedNCT00417378Phase 4
- Skeletal Muscle Oxygenation in Critically IllStatus unknownNCT00384644
- Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.CompletedNCT00324766Phase 4
- Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic ShockTerminatedNCT00314847Phase 4
- Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005CompletedNCT00157144
- A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart AttackTerminatedNCT00112281Phase 3
- Levosimendan Versus Dobutamine in Shock PatientsStatus unknownNCT00093301Phase 2/3
- Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.CompletedNCT00000552Phase 3